Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ASG Liberty All-Star Growth Fund	$5.61 +0.8%	$5.45	$4.01 ▼ $6.08	N/A	1.21	257,067 shs	199,447 shs
MDX MedX Health	C$0.07 +7.7%	C$0.08	C$0.04 ▼ C$0.10	C$18.91M	1.26	139,264 shs	10,000 shs
VPT VentriPoint Diagnostics	C$0.12	C$0.13	C$0.08 ▼ C$0.20	C$18.65M	0.39	186,362 shs	164,071 shs

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ASG Liberty All-Star Growth Fund	+1.00%	+2.59%	+0.63%	+6.01%	+1.93%
MDX MedX Health	+7.69%	+7.69%	+7.69%	-17.65%	+40.00%
VPT VentriPoint Diagnostics	+9.52%	+4.55%	-17.86%	+4.55%	-39.47%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ASG Liberty All-Star Growth Fund	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
MDX MedX Health	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
VPT VentriPoint Diagnostics	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating	Consensus Price Target	% Upside from Current Price
ASG Liberty All-Star Growth Fund	N/A	N/A	N/A
MDX MedX Health	N/A	N/A	N/A
VPT VentriPoint Diagnostics	N/A	N/A	N/A

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ASG Liberty All-Star Growth Fund	N/A	N/A	N/A	N/A	N/A	N/A
MDX MedX Health	C$510.56K	37.04	C$0.00 per share	60.00	C($0.03) per share	-2.33
VPT VentriPoint Diagnostics	C$140.67K	132.60	C$0.02 per share	5.53	C($0.02) per share	-7.36

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ASG Liberty All-Star Growth Fund	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
MDX MedX Health	-C$3.82M	-C$0.02	N/A	∞	N/A	N/A	N/A	-220.68%	N/A
VPT VentriPoint Diagnostics	-C$5.25M	-C$0.03	N/A	∞	N/A	-3,732.10%	388.60%	-136.72%	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ASG Liberty All-Star Growth Fund	$0.34	6.07%	N/A	N/A	N/A
MDX MedX Health	N/A	N/A	N/A	N/A	N/A
VPT VentriPoint Diagnostics	N/A	N/A	N/A	N/A	N/A

Latest OVN, VPT, MDX, and ASG Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/7/2025	ASG Liberty All-Star Growth Fund	quarterly	$0.12	8.3%	7/18/2025	7/18/2025	9/2/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ASG Liberty All-Star Growth Fund	N/A	N/A	N/A
MDX MedX Health	N/A	0.10	0.05
VPT VentriPoint Diagnostics	-58.56	0.28	6.67

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ASG Liberty All-Star Growth Fund	21.62%
MDX MedX Health	0.01%
VPT VentriPoint Diagnostics	N/A

Insider Ownership

Company	Insider Ownership
ASG Liberty All-Star Growth Fund	0.32%
MDX MedX Health	6.23%
VPT VentriPoint Diagnostics	2.13%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ASG Liberty All-Star Growth Fund	N/A	N/A	N/A	Not Optionable
MDX MedX Health	N/A	270.17 million	N/A	Not Optionable
VPT VentriPoint Diagnostics	147,000	162.20 million	N/A	Not Optionable

OVN, VPT, MDX, and ASG Headlines

Recent News About These Companies

Ventripoint Diagnostics Announces Private Placement and Strategic Financial Updates

August 26 at 12:13 AM | msn.com

VentriPoint Diagnostics (CVE:VPT) Shares Down 4.3% - Should You Sell?

August 21, 2025 | americanbankingnews.com

Ventripoint Diagnostics Strengthens Leadership with Key Appointment

August 18, 2025 | msn.com

CEO.CA's Inside the Boardroom: Cardiac MRI Alternative Gets FDA Nod - Ventripoint CEO on U.S. and China Sales Plans

August 13, 2025 | finance.yahoo.com

Ventripoint Diagnostics Ltd. (VPT.V) - Yahoo Finance

June 26, 2025 | finance.yahoo.com

When AI Meets Heart Care: The FDA Just Cleared A Revolutionary Cardiac Imaging Device. Here’s What You Should Know

March 15, 2025 | theglobeandmail.com

VentriPoint Diagnostics Launches Private Placement to Bolster Operations

March 14, 2025 | tipranks.com

Shares Of AI Company Surging On FDA 510(k) Clearance News

February 27, 2025 | msn.com

Ventripoint Diagnostics Announces U.S. FDA 510(k) Clearance for VMS+(TM) 4.0 Automated Radiological Image Processing Software/System

February 27, 2025 | finance.yahoo.com

Ventripoint refines AI-powered heart scanner submission to FDA

January 21, 2025 | msn.com

VentriPoint Completes Second Tranche of Convertible Debenture Offering

January 20, 2025 | tipranks.com

Ventripoint Issues Shares for Payment of Debenture Interest

January 10, 2025 | stockhouse.com

VPT:CA Stock Price

November 26, 2024 | seekingalpha.com

Ventripoint Announces New Sales Program to Accelerate Growth in U.S. Market for AI-Powered Echocardiography Solutions

November 20, 2024 | stockhouse.com

Diagnostic Medical Sonographer Salary

October 25, 2024 | money.usnews.com

Ventripoint Receives EU CE Mark for Next Generation, AI-powered Heart-scanning Technology

October 24, 2024 | finance.yahoo.com

Ventripoint to debut new AI heart-scanning tech in Europe

October 24, 2024 | msn.com

The Evolution of Cardiac Imaging: Impending Market Growth Fuels Innovation; Fusion with AI

October 24, 2024 | invezz.comI

VentriPoint Diagnostics Ltd (VPT)

October 4, 2024 | investing.com

AI Powered Heart Imaging Solutions Improve Heart Care With a Cheaper, Faster Alternative to MRIs

September 25, 2024 | invezz.comI

New MarketBeat Followers Over Time

Media Sentiment Over Time

OVN, VPT, MDX, and ASG Company Descriptions

Liberty All-Star Growth Fund NYSE:ASG

$5.60 +0.05 (+0.81%)

Closing price 03:57 PM Eastern

Extended Trading

$5.60 0.00 (0.00%)

As of 04:10 PM Eastern

Liberty All-Star Growth Fund, Inc. is a closed-ended equity mutual fund launched and managed by ALPS Advisers, Inc. It is co-managed by Weatherbie Capital, LLC, Congress Asset Management Company, and Sustainable Growth Advisers, LP. The fund invests in the public equity markets of the United States. It seeks to invest in stocks of companies operating across diversified sectors. The fund primarily invests in growth stocks of companies across all market capitalizations. It employs fundamental analysis with a bottom-up stock picking approach to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Composite Index, Russell 3000 Growth Index, and the S&P 500 Index. It conducts in-house research to make its investments. The fund was previously known as Charles Allmon Trust, Inc. Liberty All-Star Growth Fund, Inc. was formed on March 14, 1986 and is domiciled in the United States.

MedX Health CVE:MDX

C$0.07 +0.01 (+7.69%)

As of 09:50 AM Eastern

MedX Health Corp develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; and phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide treatment for pain and tissue damage in the rehabilitation market. It operates DermSecure telemedicine platform that enables the web-based operation of its SIAscopy scanning technology and allows the company to deploy its technology in networks of third-party locations from which patients' mole and lesion images along with other relevant patient information can be connected to specialist physicians for remote assessment. The company was incorporated in 1999 and is headquartered in Mississauga, Canada.

VentriPoint Diagnostics CVE:VPT

C$0.12 0.00 (0.00%)

As of 03:58 PM Eastern

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. The company also provides VMS+ software, a 2D and 3D ultrasound models. In addition, it develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging, and cardiotoxicity in oncology patients. Ventripoint Diagnostics Ltd. is headquartered in Toronto, Canada.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time